We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Company for Misleading Safety and Efficacy Claims
FDA Warns Company for Misleading Safety and Efficacy Claims
January 17, 2007
The FDA warned WellSpring Pharmaceutical for a print advertisement the agency said was misleading and overstated the safety and effectiveness of its drug, including using inappropriate studies as supporting evidence.